• All
  • 2cureX
  • Agillic
  • Amniotics
  • Aquaporin
  • Argeo
  • Ascelia Pharma
  • Asetek
  • Astralis
  • Audientes
  • BankNordik
  • Bawat
  • Better Collective
  • BioPorto
  • BoMill
  • Boozt
  • Curasight
  • DanCann Pharma
  • Danish Aerospace company
  • Danske Bank
  • DecideAct
  • DFDS
  • Digizuite
  • Djurslands Bank
  • Evaxion-Biotech
  • ExpreS2ion Biotechnologies
  • FirstFarms
  • Flügger
  • Gabriel
  • Green Hydrogen Systems
  • GreenMobility
  • H+H International
  • Hafnia
  • Hansa BioPharma
  • HusCompagniet
  • Hydract
  • Idogen
  • Impero
  • InDex Pharmaceuticals
  • MapsPeople
  • Movinn
  • NeoDynamics
  • Nexcom
  • Nordic Solar
  • North Media
  • NTG - Nordic Transportation Group
  • Odico
  • OmniCar
  • OrderYOYO
  • Penneo
  • Photocat
  • Re-Match
  • River Tech
  • Roblon
  • Saniona
  • Sanistaal
  • Scandinavian Medical Solutions
  • Scape Technologies
  • Skako
  • Skjern Bank
  • SP Group
  • Tryg
  • Valuer
  • Virogates
  • Windowmaster
  • Xplora Technologies

Anders Karlsson leaves for a new assignment and Christina Herder is appointed acting CEO

Idogen announced yesterday that Anders Karlsson has decided to leave the company to move on to a CEO role in another Swedish biotechnology company. He …

Read More →

Amniotics AB granted key U.S. patent for PulmoStem™ – Positive news!

There are currently no effective therapies that prevent or cure ARDS. There is also no drug with adequate effect against ARDS triggered by COVID-19. Acute …

Read More →
InDex Pharmaceuticals

InDex Pharmaceuticals – Annual general meeting

The annual general meeting in InDex Pharmaceuticals Holding was held on Wednesday 1 June 2022. The following resolutions, amongst others, were passed at the general …

Read More →
InDex Pharmaceuticals

InDex Pharmaceuticals gets new patent for cobitolimod granted in Europe

InDex Pharmaceuticals has announced that a new method of use patent for the drug candidate cobitolimod has been granted by the European Patent Office (EPO). …

Read More →

Amniotics – January to March in brief

Amniotics received a grant of SEK 4,8 million from Sweden’s Innovation Agency, Vinnova, together with Professor Sandra Lindstedt at Skåne University Hospital. The grant will …

Read More →

Amniotics presents positive preclinical data on stem cell treatment

Amniotics presents positive preclinical data on stem cell treatment for chemotherapy-induced peripheral neuropathy at ICRBE 2022. Amniotics has announced that an abstract with new promising …

Read More →

NeoDynamics at the largest German breast cancer congress

The MedTech company NeoDynamics showcased its novel biopsy system NeoNavia at the 41st Congress of the German Society of Senology, the most important breast cancer …

Read More →

NeoDynamics receives ethical approval for German device registry

The MedTech company NeoDynamics has received a favorable decision by the ethical committee of the Medical Association of Hesse, to establish a device registry in …

Read More →

Idogen brings together scientific advisors at the ISTH 2022 scientific conference in London

Idogen participated in the scientific conference ISTH 2022 Congress organized by the International Society on Thrombosis and Hemostasis (ISTH) on 9–13 July in London. This …

Read More →